icon-folder.gif   Conference Reports for NATAP  
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
Shifting scales: comparing viral hepatits and HIV/AIDS mortality in the Global Burden of Disease Study 2010
  Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Benjamin C. Cowie & Jennifer H. MacLachlan
WHO Regional Reference Laboratory for Hepatits B, Victorian Infectious Diseases Reference Laboratory; and The University of Melbourne
AASLD: The global burden of liver disease attributable to hepatitis B, hepatitis C, and alcohol: increasing mortality, differing causes - (11/08/13)






1.Murray CJ et al. GBD 2010: design, definitions, and metrics. Lancet 2012.
2. Lozano R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012.
3. Cowie BC, Dore GJ. The perpetual challenge of infectious diseases. NEJM 2012.
4. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action. Geneva: Global Hepatitis Programme, World Health Organisation, 2012.
5. Lemoine et al. Viral hepatitis in resource---limited countries and access to antiviral therapies: current and future challenges. Future Virology 2013.
6. Cowie et al. Mortality due to viral hepatitis in the Global Burden of Disease Study 2010: new evidence of an urgent global public health priority. Antiviral Therapy 2013.